Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thaïs Tison"'
Autor:
Julien Pierrard, David Dechambre, Christel Abdel Massih, Sophie Cvilic, Ana Da Silva Chambel Roma, Pascale Henderickx, Sofie Heylen, Eleonore Longton, Romain Mony, Mohamed Amine Tenabene, Thaïs Tison, Ad Vandermeulen, Loïc Vander Veken, Aniko Wale Etume, Anne-Emmanuella Yeo, Geneviève Van Ooteghem
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 32, Iss , Pp 100284- (2024)
Introduction: Dose-escalation radiotherapy for rectal tumours is increasingly considered as a non-operative approach, with online-adaptive radiotherapy (oART) supporting this approach by correcting inter-fraction tumour position errors. However, usin
Externí odkaz:
https://doaj.org/article/d2b987cfd93c4bfe89818405bffac3a7
Publikováno v:
Future Science OA, Vol 7, Iss 5 (2021)
A 72-year-old woman was diagnosed with metastatic colorectal cancer and treated with oxaliplatin-based chemotherapy and bevacizumab. One week after the second administration of chemotherapy, she presented acute-onset dysphagia and rapidly progressing
Externí odkaz:
https://doaj.org/article/057ec91e2dc64d169dbf08d5b2ef502d
Publikováno v:
Critical reviews in oncology/hematology, Vol. 171, p. 103600 (2022)
During the last decade, major improvements have been made in the treatment of renal cell carcinoma (RCC) with the development and use of multiple tyrosine kinase inhibitors and immune checkpoint inhibitors. Brain metastases in RCC patients (BM-RCC) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65aabcf74f0d4bf8f9e2127af9610f70
https://hdl.handle.net/2078.1/258120
https://hdl.handle.net/2078.1/258120
Autor:
Thais Tison, MD, Pierre Loap, MD, Emilie Arnaud, MD, Kim Cao, MD, Solene Bringer, MD, Manon Kissel, MD, Safia Maaradji, MD, Juliette Mainguene, MD, Jean-Yves Pierga, MD, PhD, Florence Lerebours, MD, Anne Vincent-Salomon, MD, PhD, Mariana Mirabelle, MD, Francois-Clement Bidard, MD, PhD, Delphine Loirat, MD, PhD, Youlia M. Kirova, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 3, Pp 101384- (2024)
Purpose: The current standard-of-care management of locally advanced triple negative breast cancer (TNBC) is based on neoadjuvant chemo-immunotherapy with pembrolizumab, surgery, radiation therapy (RT), and adjuvant pembrolizumab. However, the safety
Externí odkaz:
https://doaj.org/article/3f2900b13cd74ba6b3f684249c69f513